Literature DB >> 20871268

Long-term survival of a patient with squamous cell carcinoma harboring NUT gene rearrangement.

Naomi Fujioka1, Christopher A French, Michael J Cameron, Robert A Kratzke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20871268     DOI： 10.1097/JTO.0b013e3181ebaa20

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  8 in total

Review 1.  Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.

Authors:  Kyriakos Chatzopoulos; Jennifer M Boland
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

2.  Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma.

Authors:  Mammen M Puliyel; Leo Mascarenhas; Shengmei Zhou; Amita Sapra; Paola Dal Cin; Christopher A French; Rajkumar Venkatramani
Journal:  J Clin Oncol       Date:  2014-01-27       Impact factor: 44.544

Review 3.  NUT midline carcinoma: an imaging case series and review of literature.

Authors:  Aruna Polsani; Kiery A Braithwaite; Adina L Alazraki; Carlos Abramowsky; Bahig M Shehata
Journal:  Pediatr Radiol       Date:  2011-10-28

Review 4.  A review of NUT midline carcinoma.

Authors:  Edward B Stelow
Journal:  Head Neck Pathol       Date:  2011-01-08

Review 5.  An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.

Authors:  Qian W Huang; Li J He; Shuang Zheng; Tao Liu; Bei N Peng
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 6.  NUT Carcinoma-An Underdiagnosed Malignancy.

Authors:  Ulrich M Lauer; Martina Hinterleitner; Marius Horger; Paul V Ohnesorge; Lars Zender
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

7.  NUT expression in primary lung tumours.

Authors:  Marius Lund-Iversen; Krystyna Kotanska Grøholt; Åslaug Helland; Elin Borgen; Odd Terje Brustugun
Journal:  Diagn Pathol       Date:  2015-09-05       Impact factor: 2.644

8.  Comparative drug screening in NUT midline carcinoma.

Authors:  A H Beesley; A Stirnweiss; E Ferrari; R Endersby; M Howlett; T W Failes; G M Arndt; A K Charles; C H Cole; U R Kees
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.